Pennant Investors’s Zymeworks ZYME Stock Holding History

Pennant Investors’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-38,700	Closed	-$329K	–	45
2024 Q2	$329K	Hold	38,700	–	–	0.09%	29
2024 Q1	$407K	Hold	38,700	–	–	0.1%	29
2023 Q4	$402K	Buy	+38,700	New	+$308K	0.09%	29

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Pennant Investors's ZYME Position: Q3 2024 in Review

Pennant Investors sold out of Zymeworks (ZYME) in Q3 2024, closing a stake of 38,700 shares — an estimated $329K sold.

Pennant Investors first reported a position in ZYME in Q4 2023 and held it in 3 quarters. The position peaked at $407K in Q1 2024. 163 funds tracked by Wall St. Rank hold ZYME as of Q3 2024.

Pennant Investors reported no remaining Zymeworks position as of Q3 2024 after selling out during the quarter.
Pennant Investors sold 38,700 Zymeworks shares in Q3 2024, an estimated $329K.
Pennant Investors first reported a position in Zymeworks in Q4 2023 and held it in 3 quarters.
Pennant Investors's Zymeworks position peaked at $407K in Q1 2024.
163 funds tracked by Wall St. Rank held Zymeworks as of Q3 2024.

Based on Pennant Investors's 13F filing for Q3 2024, filed 14 Nov 2024.